Home Cart Sign in  
Chemical Structure| 1352879-65-2 Chemical Structure| 1352879-65-2

Structure of PF-3450074
CAS No.: 1352879-65-2

Chemical Structure| 1352879-65-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

PF-3450074 blocks HIV-1 at an early postentry stage by binding the viral capsid and interfering with its function.

Synonyms: PF-74

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of PF-3450074

CAS No. :1352879-65-2
Formula : C27H27N3O2
M.W : 425.52
SMILES Code : O=C(CC1=C(NC2=C1C=CC=C2)C)N[C@H](C(N(C3=CC=CC=C3)C)=O)CC4=CC=CC=C4
Synonyms :
PF-74
MDL No. :MFCD28160729
InChI Key :ACDFWSNAQWFRRF-VWLOTQADSA-N
Pubchem ID :49800090

Safety of PF-3450074

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HeLa-P4 10 µM 8 hours Inhibits HIV-1 reverse transcription J Virol. 2011 Jan;85(1):542-9
SupT1 cells 2 and 10 µM 16 hours To measure the effect of PF74 on HIV-1 reverse transcription, results showed that 10 μM PF74 significantly inhibited reverse transcription, while 2 μM PF74 had minimal effect J Virol. 2019 Mar 5;93(6):e01741-18
THP-1-IFIT-1 cells 10 µM 24 hours To evaluate the effect of PF-74 on HIV-1-induced ISG expression, results showed PF-74 enhanced CXCL-10 and MxA mRNA expression EMBO J. 2020 Oct 15;39(20):e103958
THP-1 cells 10 µM 24 hours To test the effect of PF-74 on HIV-1 infection, PF-74 treatment was found to induce an IFN response in HIV-1 EMBO J. 2020 Oct 15;39(20):e103958
SupT1 cells 0.08 to 20 µM 24 hours To measure the inhibitory effect of PF74 on HIV-1 infection, results showed that PF74 at low concentration (0.08 μM) could inhibit ∼20% of infection, with higher concentrations leading to stronger inhibition J Virol. 2019 Mar 5;93(6):e01741-18
TZM-GFP cells 20 µM 48 hours Evaluate the inhibitory effect of PF74 analogs on HIV-1 by measuring viral LTR-activated GFP expression. Results showed various analogs exhibited anti-HIV-1 activity. Eur J Med Chem. 2020 Aug 15;200:112427
HEK293T cells 1.39 µM 5 days PF74 treatment significantly altered HIV-1 integration site preferences, reducing targeting to transcriptionally active regions, suggesting inhibition of nuclear entry or integration steps. J Virol. 2016 May 27;90(12):5808-5823

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.35mL

0.47mL

0.24mL

11.75mL

2.35mL

1.18mL

23.50mL

4.70mL

2.35mL

References

 

Historical Records

Categories